These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 20177450

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Development of Valsartan Floating Matrix Tablets Using Low Density Polypropylene Foam Powder: In vitro and In vivo Evaluation.
    Rahamathulla M, Saisivam S, Gangadharappa HV.
    AAPS PharmSciTech; 2019 Jan 02; 20(1):35. PubMed ID: 30604045
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S, Mazumder B, Chattopadhyay S, Das MK, Sinha S, Ganguly S, De K, Mishra M.
    Int J Biol Macromol; 2014 Apr 02; 65():346-56. PubMed ID: 24472506
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Design and evaluation of a dry coated drug delivery system with floating-pulsatile release.
    Zou H, Jiang X, Kong L, Gao S.
    J Pharm Sci; 2008 Jan 02; 97(1):263-73. PubMed ID: 17803198
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Development of Buccal Adhesive Tablet with Prolonged Antifungal activity: Optimization and ex vivo Deposition Studies.
    Madgulkar A, Kadam S, Pokharkar V.
    Indian J Pharm Sci; 2009 May 02; 71(3):290-4. PubMed ID: 20490296
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Formulation and evaluation of non-effervescent floating tablets of losartan potassium.
    Getyala A, Gangadharappa HV, Prasad MS, Reddy MP, Kumar TM.
    Curr Drug Deliv; 2013 Oct 02; 10(5):620-9. PubMed ID: 23286884
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Formulation and evaluation of famotidine floating tablets.
    Jaimini M, Rana AC, Tanwar YS.
    Curr Drug Deliv; 2007 Jan 02; 4(1):51-5. PubMed ID: 17269917
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Optimization of HPMC and carbopol concentrations in non-effervescent floating tablet through factorial design.
    Acharya S, Patra S, Pani NR.
    Carbohydr Polym; 2014 Feb 15; 102():360-8. PubMed ID: 24507292
    [Abstract] [Full Text] [Related]

  • 60. Development of gastroretentive drug delivery system for cefuroxime axetil: in vitro and in vivo evaluation in human volunteers.
    Bomma R, Veerabrahma K.
    Pharm Dev Technol; 2013 Feb 15; 18(5):1230-7. PubMed ID: 22348334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.